Метицилин резистентни стафилококус ауреус (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Метицилин резистентни стафилококус ауреус" in Serbian language version.
refsWebsite
Global rank
Serbian rank
1st place
1st place
6th place
5th place
11th place
23rd place
907th place
2,996th place
low place
low place
18th place
28th place
1,258th place
4,448th place
low place
low place
low place
low place
low place
low place
archive.org
- Fang, H.; Hedin, G. (2006). „Use of cefoxitin-based selective broth for improved detection of methicillin-resistant Staphylococcus aureus”. Journal of Clinical Microbiology. 44 (2): 592—4. PMC 1392703
. PMID 16455919. doi:10.1128/JCM.44.2.592-594.2006. - Coleman, WB i Tsongalis, GJ (2006). Molecular Diagnostics: For the Clinical Laboratorian. Springer. стр. 47–56. ISBN 978-1-58829-356-5.. Humana Press. i 65-74
- Shalit, I.; Berger, S. A.; Gorea, A.; Frimerman, H. (1989). „Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital”. Antimicrob Agents Chemother. 33 (4): 593—4. PMC 172489 . PMID 2729953. doi:10.1128/AAC.33.4.593.
cdc.gov
- (језик: енглески) „Definition of MRSA, Centers for Disease Control and Prevention, USA”. Архивирано из оригинала 13. 10. 2012. г. Приступљено 12. 4. 2013.
- Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA) infections. Accessed April 17, 2011. [1], Приступљено 12. 4. 2013.
- (језик: енглески) Laboratory Detection of: Oxacillin/Methicillin-resistant Staphylococcus aureus na sajtu: „Centers for Disease Control and Prevention, USA”. 16. 5. 2019. Приступљено 12. 4. 2013.
chiroaccess.com
- (језик: енглески) Evans MW, Ramcharan M. Methicillin-Resistant Staphylococcus aureus (MRSA) and Chiropractic: What you need to know. Chiro ACCESS [Internet]; 2009. Dostupno na: „Methicillin-Resistant Staphylococcus aureus (MRSA) and Chiropractic: What you need to know”. Архивирано из оригинала 05. 03. 2016. г.
doi.org
- Lowy, F. D. (2003). „Antimicrobial resistance: the example of Staphylococcus aureus.”. Journal of Clinical Investigation. 111 (9): 1265—73. PMC 154455 . PMID 12727914. doi:10.1172/JCI18535.
- Chambers, H. F. (1997). „Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.”. Clinical Microbiology Reviews. 10 (4): 781—91. PMC 172944 . PMID 9336672. doi:10.1128/CMR.10.4.781.
- Cohen, M. L. (1992). „Epidemiology of drug resistance: implications for a post-antimicrobial era”. Science. 257 (5073): 1050—5. Bibcode:1992Sci...257.1050C. PMID 1509255. doi:10.1126/science.257.5073.1050.
- Tomasz, A. (1994). „Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop”. New England Journal of Medicine. 330 (17): 1247—1251. PMID 8139650. doi:10.1056/NEJM199404283301725.
- Swartz, M. N. (1997). „Use of antimicrobial agents and drug resistance”. New England Journal of Medicine. 337 (7): 491—2. PMID 9250853. doi:10.1056/NEJM199708143370709.
- Jevons MP. (1961). „"Celbenin"-resistant staphylococci”. BMJ. 1 (5219): 124—5. S2CID 220237793. doi:10.1136/bmj.1.5219.124-a..
- Klein, E.; Smith, D. L.; Laxminarayan R. (2007). „Hospitalizations and deaths caused by methicillin-resistantStaphylococcus aureus, United States, 1999-2005”. Emerg Infect Dis. 13 (12): 1840—6. PMC 2876761 . PMID 18258033. doi:10.3201/eid1312.070629.
- Hiramatsu K. (1997). „Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility”. J. Antimicrob. Chemother. 40 (1): 135—6. PMID 9249217. doi:10.1093/jac/40.1.135.
- Cosgrove S.E. (2003). „Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis.”. Clinical Infectious Diseases. 36 (1): 53—9. PMID 12491202. S2CID 6006764. doi:10.1086/345476..
- Klein E, Smith DL, Laxminarayan R (2007). „Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005”. Emerging Infectious Diseases. 13 (12): 1840—6. PMC 2876761 . PMID 18258033. doi:10.3201/eid1312.070629.
- Fluit, A. C.; Wielders, C. L.; Verhoef, J.; Schmitz, F. J. (2001). „Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study”. SENTRY. Journal of Clinical Microbiology. 39 (10): 3727—32. PMC 88419 . PMID 11574603. doi:10.1128/JCM.39.10.3727-3732.2001.
- Fang, H.; Hedin, G. (2006). „Use of cefoxitin-based selective broth for improved detection of methicillin-resistant Staphylococcus aureus”. Journal of Clinical Microbiology. 44 (2): 592—4. PMC 1392703 . PMID 16455919. doi:10.1128/JCM.44.2.592-594.2006.
- Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N; et al. (2004). „Methicillin-resistant Staphylococcus aureus in Europe, 1999−2002”. Emerging Infectious Diseases. 10 (9): 1627—34. PMC 3320277 . PMID 15498166. doi:10.3201/eid1009.040069..
- Lipsky; et al. (2010). „"Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost".”. Diabetologia. 53 (5): 914—923. PMID 20146051. doi:10.1007/s00125-010-1672-5.. Diabetologia.
- Tacconelli, E.; De Angelis, G.; Cataldo, M. A.; Pozzi, E.; Cauda, R. (2007). „Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis”. Journal of Antimicrobial Chemotherapy. 61 (1): 26—38. PMID 17986491. doi:10.1093/jac/dkm416.
- David, Micheal Z. and Daum, Robert S (2010). „Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic”. Clinical Microbiology Reviews. 23 (3): 616—687. PMC 2901661 . PMID 20610826. doi:10.1128/CMR.00081-09.. 23. American Society for Microbiology..
- Weber, J. T. (2005). „Community-associated methicillin-resistant Staphylococcus aureus.”. Clinical Infectious Diseases. 41: S269—72. PMID 16032563. doi:10.1086/430788. Suppl 4: S269−72.
- Naimi, T. S.; LeDell, K. H.; Como-Sabetti, K.; Borchardt, S. M.; Boxrud DJ,Etienne J; et al. (2003). „Comparison of community- and health careassociated methicillin-resistant Staphylococcus aureus infection”. JAMA. 290 (22): 2976—84. PMID 14665659. doi:10.1001/jama.290.22.2976.
- Moran, G. J.; Krishnadasan, A; Gorwitz, R. J.; Fosheim GE; Carey, R. B.; et al. (2006). „Methicillin-resistant S. aureus infectionsamong patients in the emergency department.”. New England Journal of Medicine. 355 (7): 666—74. PMID 16914702. doi:10.1056/NEJMoa055356.
- Paez, A.; Skiest, D. (2008). „MRSA: From the hospital to the community.”. Current Infect Dis Rep. 1 (10): 14—21. PMID 18377810. doi:10.1007/s11908-008-0005-z.
- Abudu L, Blair I, Fraise A, Cheng KK (2001). „Methicillin-resistantStaphylococcus aureus (MRSA): a community-based prevalence survey.”. Epidemiol Infect. 126 (3): 351—6. PMC 2869702 . PMID 11467791. doi:10.1017/S0950268801005416..
- Warshawsky B, Hussain Z, Gregson DB, Alder R, Austin M,Bruckschwaiger D; et al. (2000). „Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor.”. Infect ControlHosp Epidemiol. 21 (11): 724—7. PMID 11089657. doi:10.1086/501718..
- Nelson L, Cockram CS, Lui G, Lam R, Lam E, Lai R; et al. (2006). „Community case of methicillin-resistant Staphylococcus aureus infection.”. Emerging Infectious Diseases. 12 (1): 172—4. PMC 3291382 . PMID 16634182. doi:10.3201/eid1201.050279..
- Shalit, I.; Berger, S. A.; Gorea, A.; Frimerman, H. (1989). „Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital”. Antimicrob Agents Chemother. 33 (4): 593—4. PMC 172489 . PMID 2729953. doi:10.1128/AAC.33.4.593.
dw.de
- Brigite Osterat, Saša Bojić Novi antibiotik protiv MRSA „Deutsche Welle”. 2012. Приступљено 12. 10. 2012.
hardydiagnostics.com
- Seiken, Denka. „MRSA latex test for PBP2”. Архивирано из оригинала 10. 03. 2009. г. Приступљено 12. 10. 2012.
harvard.edu
adsabs.harvard.edu
- Cohen, M. L. (1992). „Epidemiology of drug resistance: implications for a post-antimicrobial era”. Science. 257 (5073): 1050—5. Bibcode:1992Sci...257.1050C. PMID 1509255. doi:10.1126/science.257.5073.1050.
healthinfotranslations.org
- (језик: енглески) MRSA (Methicillin Resistant Staphylococcus Aureus). 2008.. Developed through a partnership of The Ohio State University Medical Center, Mount Carmel Health, OhioHealth and Nationwide Children’s Hospital, Columbus, Ohio. Available for public use without copyright restrictions at [2], Приступљено 12. 4. 2013.
horizonpress.com
- Francois P, Schrenzel J (2008). „Rapid Diagnosis and Typing of Staphylococcus aureus”. Staphylococcus: Molecular Genetics. Caister Academic Press. ISBN 978-1-904455-29-5.
- Mackay I M (editor). (2007). Real-Time PCR in Microbiology: From Diagnosis to Characterization. Caister Academic Press. ISBN 978-1-904455-18-9.
nb.rs
doiserbia.nb.rs
- Petrović Jeremić Lj; et al. (2008). „Mehanizmi rezistencije Staphylococcus aureusa na meticilin.”. Vojnosanitetski Pregled. 65 (5): 377—382.. „UDC: 579.862.4:[615.015.8:615.33” (PDF). Приступљено 12. 4. 2013.
ni.ac.rs
publisher.medfak.ni.ac.rs
- Jovan Orlović, Marina Dinić i Branislava Kocić (2008). „Zastupljenost meticilin rezistentnih stafilokoka izolovanih iz bolesničkog materijala” (PDF). Acta Medica Medianae. 47. Архивирано из оригинала (PDF) 03. 09. 2013. г. Приступљено 21. 03. 2012.
nih.gov
ncbi.nlm.nih.gov
- Lowy, F. D. (2003). „Antimicrobial resistance: the example of Staphylococcus aureus.”. Journal of Clinical Investigation. 111 (9): 1265—73. PMC 154455 . PMID 12727914. doi:10.1172/JCI18535.
- Chambers, H. F. (1997). „Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.”. Clinical Microbiology Reviews. 10 (4): 781—91. PMC 172944 . PMID 9336672. doi:10.1128/CMR.10.4.781.
- Cohen, M. L. (1992). „Epidemiology of drug resistance: implications for a post-antimicrobial era”. Science. 257 (5073): 1050—5. Bibcode:1992Sci...257.1050C. PMID 1509255. doi:10.1126/science.257.5073.1050.
- Tomasz, A. (1994). „Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop”. New England Journal of Medicine. 330 (17): 1247—1251. PMID 8139650. doi:10.1056/NEJM199404283301725.
- Swartz, M. N. (1997). „Use of antimicrobial agents and drug resistance”. New England Journal of Medicine. 337 (7): 491—2. PMID 9250853. doi:10.1056/NEJM199708143370709.
- Klein, E.; Smith, D. L.; Laxminarayan R. (2007). „Hospitalizations and deaths caused by methicillin-resistantStaphylococcus aureus, United States, 1999-2005”. Emerg Infect Dis. 13 (12): 1840—6. PMC 2876761 . PMID 18258033. doi:10.3201/eid1312.070629.
- Hiramatsu K. (1997). „Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility”. J. Antimicrob. Chemother. 40 (1): 135—6. PMID 9249217. doi:10.1093/jac/40.1.135.
- Cosgrove S.E. (2003). „Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis.”. Clinical Infectious Diseases. 36 (1): 53—9. PMID 12491202. S2CID 6006764. doi:10.1086/345476..
- Klein E, Smith DL, Laxminarayan R (2007). „Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005”. Emerging Infectious Diseases. 13 (12): 1840—6. PMC 2876761 . PMID 18258033. doi:10.3201/eid1312.070629.
- Fluit, A. C.; Wielders, C. L.; Verhoef, J.; Schmitz, F. J. (2001). „Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study”. SENTRY. Journal of Clinical Microbiology. 39 (10): 3727—32. PMC 88419 . PMID 11574603. doi:10.1128/JCM.39.10.3727-3732.2001.
- Fang, H.; Hedin, G. (2006). „Use of cefoxitin-based selective broth for improved detection of methicillin-resistant Staphylococcus aureus”. Journal of Clinical Microbiology. 44 (2): 592—4. PMC 1392703 . PMID 16455919. doi:10.1128/JCM.44.2.592-594.2006.
- Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N; et al. (2004). „Methicillin-resistant Staphylococcus aureus in Europe, 1999−2002”. Emerging Infectious Diseases. 10 (9): 1627—34. PMC 3320277 . PMID 15498166. doi:10.3201/eid1009.040069..
- Lipsky; et al. (2010). „"Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost".”. Diabetologia. 53 (5): 914—923. PMID 20146051. doi:10.1007/s00125-010-1672-5.. Diabetologia.
- Tacconelli, E.; De Angelis, G.; Cataldo, M. A.; Pozzi, E.; Cauda, R. (2007). „Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis”. Journal of Antimicrobial Chemotherapy. 61 (1): 26—38. PMID 17986491. doi:10.1093/jac/dkm416.
- David, Micheal Z. and Daum, Robert S (2010). „Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic”. Clinical Microbiology Reviews. 23 (3): 616—687. PMC 2901661 . PMID 20610826. doi:10.1128/CMR.00081-09.. 23. American Society for Microbiology..
- Weber, J. T. (2005). „Community-associated methicillin-resistant Staphylococcus aureus.”. Clinical Infectious Diseases. 41: S269—72. PMID 16032563. doi:10.1086/430788. Suppl 4: S269−72.
- Naimi, T. S.; LeDell, K. H.; Como-Sabetti, K.; Borchardt, S. M.; Boxrud DJ,Etienne J; et al. (2003). „Comparison of community- and health careassociated methicillin-resistant Staphylococcus aureus infection”. JAMA. 290 (22): 2976—84. PMID 14665659. doi:10.1001/jama.290.22.2976.
- Moran, G. J.; Krishnadasan, A; Gorwitz, R. J.; Fosheim GE; Carey, R. B.; et al. (2006). „Methicillin-resistant S. aureus infectionsamong patients in the emergency department.”. New England Journal of Medicine. 355 (7): 666—74. PMID 16914702. doi:10.1056/NEJMoa055356.
- Paez, A.; Skiest, D. (2008). „MRSA: From the hospital to the community.”. Current Infect Dis Rep. 1 (10): 14—21. PMID 18377810. doi:10.1007/s11908-008-0005-z.
- Abudu L, Blair I, Fraise A, Cheng KK (2001). „Methicillin-resistantStaphylococcus aureus (MRSA): a community-based prevalence survey.”. Epidemiol Infect. 126 (3): 351—6. PMC 2869702 . PMID 11467791. doi:10.1017/S0950268801005416..
- Warshawsky B, Hussain Z, Gregson DB, Alder R, Austin M,Bruckschwaiger D; et al. (2000). „Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor.”. Infect ControlHosp Epidemiol. 21 (11): 724—7. PMID 11089657. doi:10.1086/501718..
- Nelson L, Cockram CS, Lui G, Lam R, Lam E, Lai R; et al. (2006). „Community case of methicillin-resistant Staphylococcus aureus infection.”. Emerging Infectious Diseases. 12 (1): 172—4. PMC 3291382 . PMID 16634182. doi:10.3201/eid1201.050279..
- Scheurich, D.; Woeltje, K. (2009). „Skin and soft tissue infections due to CA-MRSA.”. Mo Med. 106 (4): 274—6. PMID 19753919.
- Shalit, I.; Berger, S. A.; Gorea, A.; Frimerman, H. (1989). „Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital”. Antimicrob Agents Chemother. 33 (4): 593—4. PMC 172489 . PMID 2729953. doi:10.1128/AAC.33.4.593.
nwsource.com
seattletimes.nwsource.com
- (језик: енглески) Michael J. Berens and Ken Armstrong, MRSA's toll climbs, but hospital is slow to change The Seattle Times,(2008)
- Michael J. Berens and Ken Armstrong, How our hospitals unleashed a MRSA epidemic The Seattle Times (2008)
semanticscholar.org
api.semanticscholar.org
- Jevons MP. (1961). „"Celbenin"-resistant staphylococci”. BMJ. 1 (5219): 124—5. S2CID 220237793. doi:10.1136/bmj.1.5219.124-a..
- Cosgrove S.E. (2003). „Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis.”. Clinical Infectious Diseases. 36 (1): 53—9. PMID 12491202. S2CID 6006764. doi:10.1086/345476..
statistics.gov.uk
- UK Office for National Statistics Online (February 22, 2007), "MRSA Deaths continue to rise in 2005"
web.archive.org
- Jovan Orlović, Marina Dinić i Branislava Kocić (2008). „Zastupljenost meticilin rezistentnih stafilokoka izolovanih iz bolesničkog materijala” (PDF). Acta Medica Medianae. 47. Архивирано из оригинала (PDF) 03. 09. 2013. г. Приступљено 21. 03. 2012.
- (језик: енглески) „Definition of MRSA, Centers for Disease Control and Prevention, USA”. Архивирано из оригинала 13. 10. 2012. г. Приступљено 12. 4. 2013.
- (језик: енглески) Evans MW, Ramcharan M. Methicillin-Resistant Staphylococcus aureus (MRSA) and Chiropractic: What you need to know. Chiro ACCESS [Internet]; 2009. Dostupno na: „Methicillin-Resistant Staphylococcus aureus (MRSA) and Chiropractic: What you need to know”. Архивирано из оригинала 05. 03. 2016. г.
- Seiken, Denka. „MRSA latex test for PBP2”. Архивирано из оригинала 10. 03. 2009. г. Приступљено 12. 10. 2012.